| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$134 |
Actinogen June 2025 quarterly activity report & Appendix 4C
|
30 Jul 2025 8:55AM |
$0.026 |
$0.036 |
risen by
38.46%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Progress of Xanamem® clinical trials in Alzheimer's disease and depression
- Updates on study recruitment, interim analyses, and upcoming milestones
- Financial results, cash flow statement, and R&D expenditure for the quarter
- Strategic business development priorities and future outlook
- Commitment to advancing neurological disease treatments
- Comprehensive overview of operational, clinical, and financial activities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$6,031 |
Change in substantial holding
|
30 Jul 2025 8:54AM |
$2.640 |
$3.180 |
risen by
20.45%
|
|
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$2,209 |
July 2025 Investor Presentation
|
30 Jul 2025 8:54AM |
$2.960 |
$2.390 |
fallen by
19.26%
|
|
DRO - Price-sensitive ASX Announcement
Full Release
Key Points
- DroneShield focuses on counterdrone technology amid rising global defense spending.
- AI and electronic countermeasures are central to their product offerings.
- Significant market opportunity with low industry saturation.
- Smart jamming and multi-sensor systems are key components of their technology.
- Substantial growth in revenue and sales pipeline projected.
- Plans for expansion in Europe and the US.
- Leadership team prioritizes innovation and strategic growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$2,209 |
July 2025 Investor Presentation
|
30 Jul 2025 8:54AM |
$2.960 |
$2.390 |
fallen by
19.26%
|
|
DRO - Price-sensitive ASX Announcement
Full Release
Key Points
- DroneShield Limited's revenue increased by 210% in HY2025 compared to HY2024.
- SaaS revenue for DroneShield is up by 177%.
- The sales pipeline is valued at $2.33 billion as of July 2025.
- DroneShield has a cash balance of $192.0 million as of July 24, 2025.
- The company is focusing on AI-powered SaaS solutions for enhanced detection and response to drones.
- DroneShield plans to expand its portfolio to include civilian markets.
- There is a strategic emphasis on regional manufacturing and sales hubs in Europe and the U.S.
- The company is investing over $50 million annually in R&D.
- DroneShield is poised to capitalize on a $10 billion+ total addressable market (TAM) for counter-drone technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Almonty Industries Inc (AII) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$6,649 |
Almonty Appoints Brian Fox as Chief Financial Officer
|
30 Jul 2025 8:54AM |
$5.350 |
$23.090 |
risen by
331.59%
|
|
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$192 |
Q4 FY25 Quarterly Activities Report and Appendix 4C
|
30 Jul 2025 8:53AM |
$1.600 |
$3.130 |
risen by
95.63%
|
|
VFY - Price-sensitive ASX Announcement
Full Release
Key Points
- Vitrafy continued commercial roll-out of its pharmaceutical cold chain technology.
- Signed a multi-year agreement with CSL Seqirus for vaccine manufacturing applications.
- Advanced commercial discussions with other global pharmaceutical companies.
- Ongoing R&D and regulatory progress supporting new product development.
- Strengthened intellectual property portfolio with additional patent applications.
- Improved product and supply chain readiness ahead of broader commercialization.
- Positive feedback and interest from global pharmaceutical and biotech companies.
- Ongoing ESG initiatives and engagement with stakeholders.
- Reported cash flows, funding status, and financial management.
- Board and management changes to support growth and commercialization strategy.
- Outlined key priorities for further commercial expansion and investment in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$26 |
Update on Funding for Nueva Sabana Copper-Gold Mine, Cuba
|
30 Jul 2025 8:53AM |
$0.005 |
$0.008 |
risen by
60%
|
|
| Aeeris Ltd (AER) ORDINARY FULLY PAID |
Communication Services |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 8:51AM |
$0.090 |
$0.070 |
fallen by
22.22%
|
|
AER - Price-sensitive ASX Announcement
Full Release
Key Points
- Aeeris Ltd released its quarterly activities and Appendix 4C cash flow report for the period ending 31 March 2023.
- The Early Warning Network (EWN) platform continues to develop and attract new customers across government and corporate markets.
- Receipts from customers and operating expenditure for the quarter are detailed in the cash flow report.
- The company reported a stable cash position at the end of the quarter.
- Ongoing business development activities and partnerships are noted as key drivers for future growth.
- No payments other than director fees were made to related parties during the quarter.
- Aeeris is focused on innovation and expanding its customer base to drive additional market opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jade Gas Holdings Limited (JGH) ORDINARY FULLY PAID |
Energy |
$232 |
Jade Secures A$3.64m Director Loan
|
30 Jul 2025 8:50AM |
$0.032 |
$0.113 |
risen by
251.56%
|
|
JGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Jade Gas Holdings Limited has secured a director loan facility of up to A$3.64 million.
- The loan is provided by three of Jade's directors.
- Funds will be used primarily for the Mongolia CBM project and general working capital.
- Key loan terms include interest rate, security, and repayment schedule.
- The director loan demonstrates strong board support and confidence in Jade's strategy.
- The funding enables the continuation and expansion of drilling and pilot programs in Mongolia.
- The announcement details the significance of this funding for Jade’s ongoing and future commercial development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Locate Technologies Limited (LOC) ORDINARY FULLY PAID |
Information Technology |
- |
Q4 FY25 Investor Presentation
|
30 Jul 2025 8:49AM |
$0.095 |
$0.056 |
fallen by
41.05%
|
|
LOC - Price-sensitive ASX Announcement
Full Release
Key Points
- Company renamed to Locate Technologies Limited from eMudhra Limited to reflect its expanded vision.
- Strong financial performance in Q4 FY25 with significant revenue and EBITDA growth.
- Continued leadership in digital signature, identity, and digital trust solutions in India and globally.
- Expansion of product suite to cover integrated digital security and authentication platforms.
- Key partnership announcements with major technology and security firms.
- Significant new client acquisitions in enterprise and government sectors across multiple geographies.
- Increased global presence with growing contributions from North America, Europe, and APAC regions.
- Focus on compliance-driven digital transformation, targeting regulated industries.
- Investments in R&D and product innovation for digital trust, e-signature, and authentication technologies.
- Strategic positioning to benefit from global trends in cybersecurity, regulatory compliance, and digital identity adoption.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GCM Corporation Limited (GCM) ORDINARY FULLY PAID |
Materials |
$26 |
GCM US Listing Scheduled for First Half 2026
|
30 Jul 2025 8:48AM |
$0.028 |
$0.009 |
fallen by
67.86%
|
|
| SHAPE Australia Corporation Limited (SHA) ORDINARY FULLY PAID |
Industrials |
$558 |
Full Year FY25 Results Notification & Webinar Details
|
30 Jul 2025 8:47AM |
$3.980 |
$6.680 |
risen by
67.84%
|
|
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$337 |
NTA at 25.07.25 Pre-tax 144.21 Post-tax 139.25
|
30 Jul 2025 8:47AM |
$1.240 |
$1.305 |
risen by
5.24%
|
|
| Locate Technologies Limited (LOC) ORDINARY FULLY PAID |
Information Technology |
- |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 8:47AM |
$0.095 |
$0.056 |
fallen by
41.05%
|
|
LOC - Price-sensitive ASX Announcement
Full Release
Key Points
- LOC continued development and commercialisation of its proprietary Bluetooth and GPS tracking technology during the quarter.
- The company advanced its partnership with Apple, integrating its technology with Apple's Find My network to enable use with Apple devices.
- LOC focused on expanding commercial opportunities, including discussions with global brands and potential enterprise customers.
- The company invested in product development, specifically enhancing its smart tag and location tracking solutions.
- LOC reported ongoing efforts to secure additional patents and intellectual property protection.
- The company received positive feedback from initial pilots and commercial trials of its technology.
- LOC continued to explore international expansion and sales channels.
- Quarterly cash flow report (Appendix 4C) indicated operating cash outflows primarily driven by product development and staff costs.
- LOC maintained a focus on cost discipline and efficiency to extend its available cash runway.
- As at the end of the quarter, the company provided a summary of its cash position and anticipated future requirements for growth and development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$6,850 |
Dyno Nobel successfully prices $500m AMTN
|
30 Jul 2025 8:47AM |
$2.940 |
$3.905 |
risen by
32.82%
|
|
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$358 |
Appendix 4C and Quarterly Activities Report
|
30 Jul 2025 8:46AM |
$0.200 |
$0.158 |
fallen by
21.25%
|
|
BRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Brainchip continued to commercialise its AkidaTM neuromorphic processor technology during the quarter.
- The company executed strategies to expand its ecosystem through partnerships, channels, and engagement with global customers.
- Product development advanced, with several technical milestones achieved and demonstrations provided to customers.
- Brainchip focused on enabling next-generation AI at the edge, suitable for low-power and high-efficiency requirements.
- New business development efforts resulted in growing interest from automotive, industrial, and consumer sectors.
- Operational discipline was emphasised, with careful management of cash flows and expenditures.
- The company ended the quarter with a strong cash position, supporting ongoing development and commercialisation efforts.
- Brainchip participated in industry events and conferences to increase its visibility and connect with potential partners and clients.
- The report provides details on cash receipts, outflows, and financial health as required by Appendix 4C.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$392 |
Update - Notification of buy-back - RG8
|
30 Jul 2025 8:45AM |
$2.090 |
$2.750 |
risen by
31.58%
|
|
| Culpeo Minerals Limited (CPO) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Cashflow Report
|
30 Jul 2025 8:45AM |
$0.011 |
$0.009 |
fallen by
18.18%
|
|
CPO - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report covers activities ended 31 March 2023
- Culpeo Minerals focused on copper exploration in Chile, primarily at Lana Corina and Fortuna projects
- Drilling at Lana Corina returned high-grade copper results and extended known mineralisation
- Exploration at Fortuna included mapping, sampling, and geophysical surveys to identify new targets
- Total cash at end of quarter was $2.2 million
- Major cash outflows were for exploration and evaluation
- Payments to related parties were disclosed
- Company remains in compliance with ASX listing rules
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Avecho Biotechnology Limited (AVE) ORDINARY FULLY PAID |
Health Care |
$93 |
June 2025 Quarterly Activities Report & Appendix 4C
|
30 Jul 2025 8:44AM |
$0.005 |
$0.024 |
risen by
380%
|
|
AVE - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report outlines AVE's operational and financial activities for June 2025.
- Key focus on the advancement of drug delivery technologies and pharmaceutical development.
- Updates provided on strategic partnerships and ongoing clinical trials.
- Financial summary includes details on cash flow, R&D expenditure, and operational costs.
- Discussion of milestones achieved and challenges faced during the reporting period.
- Outlook on future commercialization and business strategy provided for stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Torque Metals Limited (TOR) ORDINARY FULLY PAID |
Materials |
$159 |
Extension of gold mineralisation at Paris
|
30 Jul 2025 8:44AM |
$0.220 |
$0.255 |
risen by
15.91%
|
|
TOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Torque Metals Limited extended gold mineralisation at the Paris Gold Project.
- Recent drilling has identified new zones and extended known high-grade lodes.
- Results indicate a larger mineralised system than previously interpreted.
- Detailed drilling results and geological interpretations are provided.
- The company plans further exploration and resource definition drilling.
- Potential for increased overall resource and further discoveries is highlighted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$389 |
Update - Notification of buy-back - PE1
|
30 Jul 2025 8:44AM |
$1.300 |
$1.460 |
risen by
12.31%
|
|
| Scalare Partners Holdings Limited (SCP) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2025 8:44AM |
$0.180 |
$0.050 |
fallen by
72.22%
|
|
SCP - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities and Appendix 4C Cash Flow Report released for the quarter ended 31 March 2024
- Continued strategic advisory and investment support to portfolio companies
- Detailed breakdown of cash flows for operating, investing, and financing activities
- Prudent management of cash resources and focus on future growth opportunities
- Operational updates and summary of core business activities during the quarter
- Commitment to maintaining operational discipline and meeting ASX compliance requirements
- Future outlook commentary provided along with relevant disclosures
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
- |
Update - Notification of buy-back - VG1
|
30 Jul 2025 8:44AM |
$1.775 |
$1.950 |
risen by
9.86%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$6 |
Jun25 Quarterly Activities Statement and Appendix 4C
|
30 Jul 2025 8:43AM |
$0.019 |
$0.008 |
fallen by
57.89%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly Activities Statement covers the period ending June 2024.
- Details provided on product development and new commercial agreements.
- Emphasis on revenue growth and operational cost management.
- Breakdown of cash flows, including receipts from customers and operating payments.
- Update on strategic initiatives and market expansion.
- Appendix 4C offers detailed financial disclosure and cash management information.
- Company continues progress toward stated growth objectives.
- Discussion of future business outlook and planned initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$77 |
Australian Ethics Clearance for Pancreatic Cancer Trial
|
30 Jul 2025 8:43AM |
$0.235 |
$0.150 |
fallen by
36.17%
|
|
Call 1300 880 160
Start a chat
Schedule a call
